Terrance P. Coyne insider trades
Open-market stock purchases and sales by Terrance P. Coyne, EVP & CFO at Royalty Pharma plc, from SEC Form 4 filings since Jun 15, 2020.
Track record: 100% of 2 scored buys are up 5% or more since purchase, averaging +108%.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Aug 13, 2026 | RPRX Royalty Pharma plc | Sold | $105K |
| Aug 13, 2026 | RPRX Royalty Pharma plc | Sold | $541K |
| Aug 7, 2026 | RPRX Royalty Pharma plc | Sold (not open market) | — |
| Aug 5, 2026 | RPRX Royalty Pharma plc | Bought (not open market) | — |
| May 26, 2026 | RPRX Royalty Pharma plc | Sold | $3.5M |
| May 6, 2026 | RPRX Royalty Pharma plc | Bought (not open market) | — |
| Apr 28, 2026 | RPRX Royalty Pharma plc | Sold | $1.6M |
| Apr 28, 2026 | RPRX Royalty Pharma plc | Sold | $93.3K |
| Apr 1, 2026 | RPRX Royalty Pharma plc | Sold | $90.6K |
| Apr 1, 2026 | RPRX Royalty Pharma plc | Sold | $1.6M |
| Mar 23, 2026 | RPRX Royalty Pharma plc | Sold | $1.5M |
| Mar 23, 2026 | RPRX Royalty Pharma plc | Sold | $85.4K |
| Mar 2, 2026 | RPRX Royalty Pharma plc | Sold | $1M |
| Mar 2, 2026 | RPRX Royalty Pharma plc | Sold | $490K |
| Mar 2, 2026 | RPRX Royalty Pharma plc | Sold | $60.3K |
| Mar 2, 2026 | RPRX Royalty Pharma plc | Sold | $27.4K |
| Feb 23, 2026 | RPRX Royalty Pharma plc | Sold | $1.5M |
| Feb 23, 2026 | RPRX Royalty Pharma plc | Sold | $85K |
| Feb 11, 2026 | RPRX Royalty Pharma plc | Bought (not open market) | — |
| Feb 4, 2026 | RPRX Royalty Pharma plc | Sold | $826K |
| Feb 4, 2026 | RPRX Royalty Pharma plc | Sold | $47.1K |
| Feb 3, 2026 | RPRX Royalty Pharma plc | Sold | $4.7M |
| Feb 3, 2026 | RPRX Royalty Pharma plc | Sold | $265K |
| Feb 2, 2026 | RPRX Royalty Pharma plc | Sold | $246K |
| Feb 2, 2026 | RPRX Royalty Pharma plc | Sold | $4.3M |
Companies traded
- RPRX Royalty Pharma plc: 2 buys, 48 sales, last Aug 13, 2026